Pyxis Oncology Inc Cash Flow Reinvestment Rate
Latest as of June 2021:
0.14x
Pyxis Oncology Inc cash flow reinvestment rate. Pyxis Oncology Inc (PYXS) has a Cash Flow Reinvestment Rate of 0.14x as of June 2021, reinvesting $396.00K (capex $371.00K plus investments $-25.00K) from operating cash flow of $2.86 Million. Explore PYXS operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.14x
(Capex + Investments) / Operating CF
Total Reinvested
$396.00K
Capex + Investments
Operating Cash Flow
$2.86 Million
USD
Capital Expenditures
$371.00K
USD
Pyxis Oncology Inc Cash Flow Reinvestment Rate by Year (None–None)
Pyxis Oncology Inc cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Pyxis Oncology Inc. For the full cash flow conversion analysis, see how efficiently does Pyxis Oncology Inc generate cash.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow